TSMC stock slips before U.S. open after record profit; big capex plan back in focus
15 January 2026
1 min read

TSMC stock slips before U.S. open after record profit; big capex plan back in focus

New York, Jan 15, 2026, 04:54 EST — Premarket

  • TSMC shares dipped roughly 1% in premarket trading despite the chipmaker reporting a record quarterly profit.
  • Investors are balancing a larger 2026 spending plan with margin goals and demand fueled by AI.
  • Semiconductor stocks are tracking each other as the U.S. market opens.

Taiwan Semiconductor Manufacturing Co’s shares listed in the U.S. dropped 1.2% in premarket trading Thursday, despite the chipmaker posting a record-breaking fourth-quarter profit that surpassed expectations. 1

This print matters because TSMC dictates the rhythm for the entire chip supply chain — spanning from equipment manufacturers to leading AI chip designers. The market is weighing whether the upcoming phase hinges on demand or spending.

This comes as investors shift their attention to 2026 budgets, with chipmakers once more discussing capacity expansion instead of cuts.

TSMC reported a 20.5% jump in fourth-quarter revenue to NT$1,046.09 billion, while net income surged 35.0% to NT$505.74 billion. Gross margin hit 62.3%. The company projects first-quarter revenue between $34.6 billion and $35.8 billion, with gross margin forecasted at 63% to 65%. It also announced a 2026 capital budget of $52 billion to $56 billion for plant and equipment. CFO Wendell Huang noted that demand for its advanced process technologies remains robust as they head into the first quarter. 2

On the earnings call, CEO C.C. Wei sounded more cautious about the AI surge. “I’m also very nervous about it,” he admitted, citing the scale of the spending plan and the importance of verifying customer demand. 3

The impact spread through the sector. In Europe, ASML shares surged to an all-time high, briefly vaulting the chip-equipment giant’s market cap beyond $500 billion, Reuters reported. The jump came as investors digested TSMC’s earnings and saw potential upside. 4

TSMC stock now hinges on whether its stronger profits and raised near-term revenue outlook can outweigh concerns that increased investment and overseas expansion might limit short-term gains.

Traders will be eyeing how much of the recent surge in AI-related chip stocks is already priced in, as well as how the market responds to TSMC’s margin goals while it ramps up advanced manufacturing.

The downside risk remains. Should AI demand falter or cost pressures from new fabs and strained supply chains increase more quickly than anticipated, that confident spending plan could end up pinching profitability.

Stock Market Today

GOOG stock price: Alphabet’s $185 billion AI spend plan keeps Google shares on edge into Monday

GOOG stock price: Alphabet’s $185 billion AI spend plan keeps Google shares on edge into Monday

7 February 2026
New York, Feb 7, 2026, 09:34 EST — Market closed. Alphabet’s non-voting Class C shares (GOOG) closed down 2.48% at $323.10 on Friday, extending a pullback after the Google parent flagged a sharp jump in spending tied to artificial intelligence. 1 With U.S. markets shut for the weekend, the near-term test is whether investors keep treating Big Tech’s AI build-out as a cost problem before it becomes a growth story. A Reuters review of the week’s trading showed fresh jitters around 2026 outlays across the sector, and SanJac Alpha chief investment officer Andrew Wells said the AI trade “got too
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Aldi pay rise 2026: UK staff get March bump and longer maternity pay, Ireland hits €15.40 living wage
Previous Story

Aldi pay rise 2026: UK staff get March bump and longer maternity pay, Ireland hits €15.40 living wage

ASML stock hits record high as market value tops $500 billion after TSMC blowout
Next Story

ASML stock hits record high as market value tops $500 billion after TSMC blowout

Go toTop